PANCREATOGENOUS DIABETES

PANCREATOGENOUS DIABETES was reported 65 times

These drug classes are most commonly taken by patients reporting PANCREATOGENOUS DIABETES:

# Drug Count
0 Insulin Analog [EPC] 7
1 Programmed Death Receptor-1 Blocking Antibody [EPC] 7
2 Corticosteroid [EPC] 6
3 Platinum-based Drug [EPC] 6
4 Nitrofuran Antibacterial [EPC] 5
5 Alkylating Drug [EPC] 4
6 Benzodiazepine [EPC] 4
7 CD20-directed Cytolytic Antibody [EPC] 4
8 Folate Analog Metabolic Inhibitor [EPC] 4
9 GLP-1 Receptor Agonist [EPC] 4
10 Nucleoside Metabolic Inhibitor [EPC] 4
11 Proton Pump Inhibitor [EPC] 4
12 RANK Ligand Inhibitor [EPC] 4
13 Nonsteroidal Anti-inflammatory Drug [EPC] 3
14 Platelet Aggregation Inhibitor [EPC] 3
15 Vitamin B12 [EPC] 3
16 HMG-CoA Reductase Inhibitor [EPC] 2
17 Histamine-2 Receptor Antagonist [EPC] 2
18 Integrin Receptor Antagonist [EPC] 2
19 Orexin Receptor Antagonist [EPC] 2
20 Peroxisome Proliferator Receptor alpha Agonist [EPC] 2
21 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 2
22 Thiazide Diuretic [EPC] 2
23 Tumor Necrosis Factor Blocker [EPC] 2
24 Vitamin C [EPC] 2
25 Vitamin D [EPC] 2
26 Aldosterone Antagonist [EPC] 1
27 Aluminum Complex [EPC] 1
28 Aminosalicylate [EPC] 1
29 Androgen [EPC] 1
30 Angiotensin Converting Enzyme Inhibitor [EPC] 1
31 Anti-anginal [EPC] 1
32 Anti-epileptic Agent [EPC] 1
33 Antidote [EPC] 1
34 Asparagine-specific Enzyme [EPC] 1
35 Atypical Antipsychotic [EPC] 1
36 BCL-2 Inhibitor [EPC] 1
37 Bile Acid [EPC] 1
38 CTLA-4-directed Blocking Antibody [EPC] 1
39 Cytochrome P450 3A Inhibitor [EPC] 1
40 Endoglycosidase [EPC] 1
41 Factor Xa Inhibitor [EPC] 1
42 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 1
43 Interleukin-23 Antagonist [EPC] 1
44 Loop Diuretic [EPC] 1
45 Mood Stabilizer [EPC] 1
46 Osmotic Laxative [EPC] 1
47 P2Y12 Platelet Inhibitor [EPC] 1
48 Programmed Death Ligand-1 Blocker [EPC] 1
49 Protease Inhibitor [EPC] 1
50 Provitamin D2 Compound [EPC] 1
51 Radiographic Contrast Agent [EPC] 1
52 Serotonin and Norepinephrine Reuptake Inhibitor [EPC] 1
53 Serotonin-3 Receptor Antagonist [EPC] 1
54 Somatostatin Analog [EPC] 1
55 Topoisomerase Inhibitor [EPC] 1